PTAB: Patent Drawings Without Precise Measurements May Be Relied Upon as Prior Art, but Only for What They Clearly Show

August 21, 2024

Reading Time : 2 min

The Patent Trial and Appeal Board denied institution of an inter partes review petition because a prior art patent figure did not provide exact dimensions, and therefore could not meet the relevant claim limitation.  On review from the denied institution, the Director explained that a drawing may be relied upon for what it clearly shows, vacating and remanding for a determination of whether the reference is clear on its face or reasonably would have suggested the limitation in view of the supporting expert testimony.

The challenged patent claims require that a certain component of a motor vehicle radiator is placed within 10 inches of an inlet. Petitioner relied on expert testimony explaining that a prior art patent drawing depicted an edge of such a component lining the inlet’s internal wall to be “explicitly shown at the inlet.” Petitioner argued that a person of ordinary skill would thus have understood this placement to be necessarily within 10 inches of the inlet. The board disagreed, holding that patent drawings cannot be relied upon to show particular sizes if the specification is silent on the issue. Here, petitioner’s expert admitted the reference did not provide exact dimensions, and thus the petitioner could not show that the component was within 10 inches of the inlet, as claimed. Petitioner requested Director Review arguing that the drawing’s placement of the device “at” the inlet necessarily meets the requirement that it be placed within 10 inches of the inlet, as its expert explained.

The Director granted review and explained that a patent drawing may be relied on for what it clearly shows. Here, the board erred by failing to address petitioner’s argument that the figure was clear on its face and shows the component “at” the inlet. The Director vacated and remanded to the board for further determination as to whether the figure is clear on its face or reasonably suggests the placement of the component within 10 inches of the inlet, and whether the expert testimony provides sufficient explanation as to why the feature was disclosed or obvious based on the disclosure.

On remand the board denied institution again. Adopting petitioner’s construction of “inlet” to mean “the center axis of [an] . . . inlet,” the board concluded that the prior art patent drawing did not clearly show, or reasonably suggest, that the component’s placement met the 10-inch limitation because it provided no dimensions. Additionally, petitioner’s expert testimony did not show that the depicted inlet necessarily had a radius less than 10 inches. Petitioner ultimately could not show a reasonable likelihood of prevailing on at least one of the challenged claims.

Practice Tip: Patent drawings without precise measurements may be relied upon for what they clearly show. Petitioners relying on such drawings should support their argument with expert testimony explaining why the figure clearly shows the feature in question. And patent owners facing such a challenge should be ready to explain why the contested limitation is not clear from the figure, especially where the disclosure does not provide precise dimensions.

MAHLE Behr Charleston Inc. v. Frank Amidio Catalano, IPR2023-00861, Papers 15, 18, and 20 (PTAB July 26, 2024)

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.